Panniculitis affecting regions of neck and back

M13_PANNICULITIS

panniculitis: a group of diseases whose hallmark is inflammation of subcutaneous adipose tissue (the fatty layer under the skin - panniculus adiposus). Symptoms include tender skin nodules, and systemic signs such as weight loss and fatigue.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M54.0 Cause of death: ICD-10 — M54.0 2 out of 7 registries used, show all original rules.	1549
4. Check minimum number of events None	1549
5. Include endpoints None	1549
6. Filter based on genotype QC (FinnGen only)	1549

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M54
Name in latin: Panniculitis dorsi

NAME	M13_PANNICULITIS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M540
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M540
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Panniculitis affecting regions of neck and back based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11769	7023	4671
Only index persons	10796	6492	4304
Unadjusted period prevalence (%)
Whole population	0.17	0.20	0.13
Only index persons	0.21	0.24	0.16
Median age at first event (years)
Whole population	52.31	53.52	50.27
Only index persons	50.66	51.95	48.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1549	965	584
Unadjusted period prevalence (%)	0.30	0.33	0.26
Median age at first event (years)	50.17	48.21	53.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1384: Matched controls
13839

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

93.9

323.0

485

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

+∞

323.0

1384

M54.5

ICD-10 Finland

Low back pain

9.1

284.2

770

1677

M48.0

ICD-10 Finland

Spinal stenosis

96.6

267.4

291

M54.4

ICD-10 Finland

Lumbago with sciatica

15.1

267.3

481

470

M54.9

ICD-10 Finland

Dorsalgia, unspecified

18.7

240.3

389

284

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

74.9

236.5

267

N03AX16

ATC

pregabalin; oral

8.6

231.3

599

1126

N02AX02

ATC

tramadol; systemic, rectal

6.6

226.4

869

2827

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

38.2

208.0

267

N03AX12

ATC

gabapentin; oral

11.1

197.2

409

502

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

22.3

184.2

276

153

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

162.3

164.5

171

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.0

149.4

324

412

M03BX02

ATC

tizanidine; oral

4.4

131.7

1052

5819

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

167.0

117.3

122

L03

ICPC

Low back symptom/complaint

4.7

109.4

450

1291

M54.3

ICD-10 Finland

Sciatica

20.0

107.3

165

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.5

103.7

782

3755

N06AX21

ATC

duloxetine; oral

7.3

102.4

268

441

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

57.3

94.1

111

M03BC01

ATC

orphenadrine (citrate); systemic

3.9

91.1

459

1550

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

30.9

88.6

119

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.3

88.3

627

2769

N06AA09

ATC

amitriptyline; systemic

6.7

86.4

238

415

M01AH05

ATC

etoricoxib; oral

3.1

84.4

922

5432

M54.1

ICD-10 Finland

Radiculopathy

28.0

84.2

116

M79.6

ICD-10 Finland

Pain in limb

3.2

80.4

591

2625

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

283.4

79.4

R51.80

ICD-10 Finland

Headache

4.5

77.3

308

819

M01AB05

ATC

diclofenac; systemic, rectal

3.0

77.0

1018

6600

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

14.4

74.8

130

A02BC03

ATC

lansoprazole; oral

3.2

73.1

510

2149

A02BC02

ATC

pantoprazole; systemic

2.9

72.9

967

6159

N02BE01

ATC

paracetamol; systemic, rectal

4.0

72.3

1243

9481

M25.5

ICD-10 Finland

Pain in joint

3.2

70.9

488

2028

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.1

68.1

476

1989

M47.82

ICD-10 Finland

Other spondylosis, cervical region

32.0

67.8

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

35.7

65.0

M47.9

ICD-10 Finland

Spondylosis, unspecified

70.9

64.9

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

175.8

64.6

N02AJ06

ATC

codeine and paracetamol; systemic

2.8

64.4

572

2771

M53.1

ICD-10 Finland

Cervicobrachial syndrome

5.2

62.1

208

452

N02AA05

ATC

oxycodone; systemic

4.3

61.3

257

704

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

58.8

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

58.8

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

58.5

432

1837

M54.6

ICD-10 Finland

Pain in thoracic spine

7.4

58.4

146

217

M01AH01

ATC

celecoxib; oral (coxibs)

3.4

58.3

325

1131

M54.2

ICD-10 Finland

Cervicalgia

7.5

57.8

143

209

M45

ICD-10 Finland

Ankylosing spondylitis

205.2

57.5

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.1

57.5

381

1504

Z01.8

ICD-10 Finland

Other specified special examinations

3.1

56.7

369

1433

L86

ICPC

Back syndrome with radiating pain

10.1

55.5

114

122

A02BC05

ATC

esomeprazole; systemic

2.5

55.3

624

3390

M43.1

ICD-10 Finland

Spondylolisthesis

30.7

54.6

H02AB06

ATC

prednisolone; systemic

2.5

54.5

691

3985

A02BC01

ATC

omeprazole; systemic

2.8

54.2

447

2021

M01AE03

ATC

ketoprofen; systemic, rectal

2.5

53.7

595

3185

M01AH02

ATC

rofecoxib; oral

4.0

53.2

235

669

G54.0

ICD-10 Finland

Brachial plexus disorders

18.9

53.0

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

537.6

52.8

R03AC02

ATC

salbutamol; inhalant

2.4

52.6

777

4816

N06AX11

ATC

mirtazapine; oral

2.6

52.2

495

2422

M03BC51

ATC

orphenadrine, combinations; systemic

2.7

51.0

457

2156

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

505.2

49.7

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

22.6

48.8

M01AE02

ATC

naproxen; oral, rectal

2.3

48.3

810

5249

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

+∞

48.2

G44.2

ICD-10 Finland

Tension-type headache

3.6

48.0

240

756

R06.0

ICD-10 Finland

Dyspnoea

2.8

46.8

374

1634

L28

ICPC

Limited function/disability (L)

3.4

46.4

254

857

M54.8

ICD-10 Finland

Other dorsalgia

9.1

45.8

116

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

45.5

351

1496

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

22.3

45.2

J01AA02

ATC

doxycycline; systemic

2.5

44.9

1101

8437

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.6

44.7

166

397

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

13.4

44.7

M01AC06

ATC

meloxicam; systemic, rectal

2.4

44.5

540

2952

R52.2

ICD-10 Finland

Other chronic pain

9.4

43.9

105

N06AX16

ATC

venlafaxine; oral

3.4

43.5

239

806

UJF32

NOMESCO Finland

Coloscopy

2.6

43.3

385

1777

M79.0

ICD-10 Finland

Rheumatism, unspecified

10.4

42.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

42.0

407

1968

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

23.2

41.7

A02BA02

ATC

ranitidine; systemic

2.8

41.7

313

1304

M50.3

ICD-10 Finland

Other cervical disc degeneration

36.7

41.5

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

69.3

41.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.1

40.8

254

933

N03AE01

ATC

clonazepam; systemic

5.6

40.7

124

238

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

211.0

40.1

M54

ICD-10 Finland

Dorsalgia

3.6

39.9

195

597

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.8

39.1

179

519

M79.1

ICD-10 Finland

Myalgia

3.2

39.1

224

776

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.0

39.0

260

998

J01MA02

ATC

ciprofloxacin; systemic

2.2

39.0

551

3186

A06AD11

ATC

lactulose; oral

3.1

38.9

236

851

N05CF01

ATC

zopiclone; oral

2.3

38.5

468

2517

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

38.3

212

715

R52.9

ICD-10 Finland

Pain, unspecified

4.1

37.9

157

416

J01DB01

ATC

cefalexin; oral

2.4

37.2

1145

9215

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.3

37.2

440

2329

J01FA06

ATC

roxithromycin; oral

2.1

36.7

589

3577

Z50.1

ICD-10 Finland

Other physical therapy

5.2

36.0

117

242

9211

FHL

Exploration or removal of diskusprolapse

189.9

35.9

M01AX17

ATC

nimesulide; oral

2.4

35.8

355

1713

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

35.7

268

1103

SAA01

NOMESCO Finland

Simple examination of mouth

2.1

35.6

974

7329

L02

ICPC

Back symptom/complaint

3.8

35.1

159

455

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.0

34.9

684

4481

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.1

34.8

213

767

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

34.5

580

3562

R42

ICD-10 Finland

Dizziness and giddiness

2.5

34.3

311

1426

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.7

34.1

266

1121

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

34.0

254

1042

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.8

33.6

150

424

J01DA01

ATC

[U] cefalexin; systemic

2.0

33.3

882

6453

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

33.3

386

2002

N02AC04

ATC

dextropropoxyphene; oral

7.8

33.2

105

N06AB04

ATC

citalopram; systemic

2.4

33.0

323

1538

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.4

33.0

113

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

11.1

32.9

M70.6

ICD-10 Finland

Trochanteric bursitis

3.3

32.8

177

582

A01

ICPC

Pain general/multiple sites

4.2

32.7

133

345

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.9

32.6

144

403

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.7

32.4

154

458

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.4

32.3

319

1524

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

32.1

352

1773

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.0

32.1

766

5345

J01FF01

ATC

clindamycin; systemic

2.2

32.1

399

2134

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

31.9

424

2333

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

168.9

31.8

R4110

NOMESCO Finland

Physiotherapy

2.2

31.6

381

2007

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

31.5

285

1299

M35.7

ICD-10 Finland

Hypermobility syndrome

20.2

31.5

M79.7

ICD-10 Finland

Fibromyalgia

8.1

31.4

N06AA10

ATC

nortriptyline; systemic

10.8

31.4

R07.3

ICD-10 Finland

Other chest pain

3.5

30.8

157

494

L01

ICPC

Neck symptom/complaint

2.9

30.5

204

778

ZXA00

NOMESCO Finland

Right side

2.2

30.4

384

2060

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

30.1

266

1193

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

4.3

30.0

116

287

M01AE01

ATC

ibuprofen; systemic, rectal

2.5

29.9

1236

10624

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

29.6

276

1274

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.8

29.4

N05BA01

ATC

diazepam; systemic, rectal

2.8

29.2

206

809

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.2

29.1

115

290

P01AB01

ATC

metronidazole; oral, rectal

2.0

29.1

561

3565

X58

ICD-10 Finland

Exposure to other specified factors

2.7

28.9

220

905

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.4

28.8

149

473

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

28.4

235

1015

M02AA07

ATC

piroxicam; topical

2.0

28.1

497

3045

AA1AD

NOMESCO Finland

CT of head and brain

2.2

27.9

319

1626

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

79.3

27.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.8

27.7

124

350

R53

ICD-10 Finland

Malaise and fatigue

2.3

27.1

295

1464

TAB20

NOMESCO Finland

Epidural puncture

32.6

26.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

26.7

538

3444

N05CD07

ATC

temazepam; oral

2.8

26.7

185

718

M01AX01

ATC

nabumetone; oral

5.3

26.2

162

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

26.1

M53.2

ICD-10 Finland

Spinal instabilities

+∞

26.1

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

+∞

26.1

M01AB55

ATC

diclofenac, combinations; oral

3.8

25.6

113

315

C03CA01

ATC

furosemide; systemic

2.1

25.4

353

1949

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.2

25.4

164

WX110

NOMESCO Finland

Local anesthesy

1.8

25.3

912

7076

N05AH04

ATC

quetiapine; oral

2.4

25.3

230

1041

H02AB07

ATC

prednisone; oral

2.5

25.1

216

949

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

30.7

25.1

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

24.8

293

1505

R52.1

ICD-10 Finland

Chronic intractable pain

32.7

24.7

S18

ICPC

Laceration/cut

1.9

24.7

521

3368

SPAT1153

SPAT

Removal of sutures

2.0

24.6

414

2464

SPAT1254

SPAT

Administration of medicine

2.5

24.5

204

879

N05BA04

ATC

oxazepam; oral

2.1

24.5

339

1864

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.8

24.3

702

5035

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.2

24.0

271

1359

K59.09

ICD-10 Finland

Constipation, unspecified

4.2

24.0

240

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

24.0

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

24.0

231

1075

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

23.9

296

1550

M43.0

ICD-10 Finland

Spondylolysis

88.3

23.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.7

23.6

178

724

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

27.2

23.6

L17

ICPC

Foot/toe symptom/complaint

2.1

23.5

318

1728

J01FA10

ATC

azithromycin; systemic

1.8

23.4

770

5725

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

47.5

23.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

23.3

277

1424

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

8.7

23.2

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

13.2

23.0

R02

ICPC

Shortness of breath/dyspnoea

2.8

22.9

163

639

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.8

22.9

101

282

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

4.0

22.8

252

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

22.8

235

1129

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.7

22.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

22.7

415

2531

R03BA02

ATC

budesonide; inhalant

2.3

22.6

247

1216

R01AD09

ATC

mometasone; nasal

1.8

22.6

598

4132

R06AE07

ATC

cetirizine; oral

1.8

22.5

582

3995

A07EC01

ATC

sulfasalazine; oral, rectal

3.2

22.3

122

403

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

22.2

392

2357

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

+∞

21.9

N05BA12

ATC

alprazolam; oral

2.7

21.9

162

652

L08

ICPC

Shoulder symptom/complaint

2.2

21.9

244

1213

Z71.8

ICD-10 Finland

Other specified counselling

2.0

21.8

325

1830

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.9

21.8

142

527

N06AB10

ATC

escitalopram; oral

2.1

21.7

283

1506

WX308

NOMESCO Finland

Sacral anesthesy

223.3

21.7

UJD02

NOMESCO Finland

Gastroscopy

4.1

21.6

219

ZXA05

NOMESCO Finland

Left side

2.0

21.5

331

1885

SPAT1301

SPAT

No procedures

1.9

21.4

404

2485

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.7

21.4

267

M01AB08

ATC

etodolac; oral

3.2

21.2

117

389

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.1

21.2

122

418

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

21.2

176

756

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

34.4

21.2

TAC99

NOMESCO Finland

Other blockade for chronic pain

24.6

20.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

20.8

177

769

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

20.7

162

672

N01

ICPC

Headache

2.8

20.7

137

514

M03BX01

ATC

baclofen; systemic

8.2

20.6

XA402

NOMESCO Finland

ENMG

7.6

20.5

SPAT1263

SPAT

Sampling

1.8

20.5

546

3749

A28

ICPC

Limited function/disability NOS

2.4

20.4

184

824

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.8

20.3

141

543

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.9

20.2

100

K30

ICD-10 Finland

Functional dyspepsia

2.7

20.2

151

609

K02.1

ICD-10 Finland

Caries of dentine

1.7

20.2

736

5539

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

4.3

20.2

184

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

20.1

829

6467

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

20.0

502

3373

WZA90

NOMESCO Finland

Other doctors statement

2.0

20.0

296

1656

SPAT1216

SPAT

Assessment of functional ability

2.3

19.8

193

898

N03AX09

ATC

lamotrigine; oral

4.1

19.8

197

J01MA12

ATC

levofloxacin; systemic

2.1

19.8

241

1245

G43.9

ICD-10 Finland

Migraine, unspecified

3.6

19.7

269

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

19.7

346

2062

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

19.6

142

563

G83.4

ICD-10 Finland

Cauda equina syndrome

106.5

19.6

R20.2

ICD-10 Finland

Paraesthesia of skin

3.2

19.6

108

359

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

18.0

19.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

19.5

552

3840

R55

ICD-10 Finland

Syncope and collapse

2.6

19.5

154

641

C07AA05

ATC

propranolol; systemic

2.1

19.5

262

1411

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

4.4

19.3

168

R03BB04

ATC

tiotropium bromide; inhalant

2.8

19.2

132

506

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.7

19.2

533

3683

C07AB07

ATC

bisoprolol; oral

1.7

19.2

560

3930

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

19.1

502

3409

G47.3

ICD-10 Finland

Sleep apnoea

2.0

19.1

277

1532

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

19.1

151

629

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

19.1

191

901

S06.0

ICD-10 Finland

Concussion

2.6

19.0

144

586

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

34.8

18.9

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.7

18.9

739

5630

J02AC01

ATC

fluconazole; systemic

1.7

18.9

541

3770

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.2

18.9

104

346

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

+∞

18.8

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

4.3

18.8

168

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.4

18.7

281

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.5

18.6

149

625

Z00.0

ICD-10 Finland

General medical examination

2.1

18.6

240

1267

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

192.4

18.6

L13

ICPC

Hip symptom/complaint

2.3

18.4

184

865

B01AB05

ATC

enoxaparin; parenteral

1.8

18.4

380

2386

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.3

18.3

188

895

R05

ICPC

Cough

2.0

18.3

287

1635

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

4.4

18.2

159

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.5

18.1

146

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

18.1

121

456

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

8.2

18.1

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.4

17.9

274

A02BC04

ATC

rabeprazole; oral

2.8

17.8

120

456

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

17.8

182

866

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

17.8

512

3555

WX002

NOMESCO Finland

Sedation and analgesia

2.0

17.7

260

1442

W19

ICD-10 Finland

Unspecified fall

2.6

17.6

133

541

UKC02

NOMESCO Finland

Cystoscopy

2.2

17.5

200

998

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

17.5

173

809

J46

ICD-10 Finland

Status asthmaticus

5.6

17.5

R03DC03

ATC

montelukast; oral

2.1

17.4

212

1089

H02AB04

ATC

methylprednisolone; systemic

2.2

17.3

192

947

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.7

17.2

125

496

J01CA04

ATC

amoxicillin; systemic

1.7

17.2

1062

9067

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

17.2

152

672

R13

ICD-10 Finland

Dysphagia

3.2

17.2

305

WX290

NOMESCO Finland

Other blockade of nerve

1.7

17.2

569

4098

L12

ICPC

Hand/finger symptom/complaint

2.2

17.2

183

887

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.4

17.2

156

699

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

17.1

252

1398

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

17.0

225

1197

R11

ICD-10 Finland

Nausea and vomiting

2.8

17.0

115

437

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.5

17.0

137

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

17.0

186

913

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

16.9

654

4906

M01AH03

ATC

valdecoxib; oral

3.0

16.9

344

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

16.9

129

528

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.5

16.8

233

L29

ICPC

Musculoskeletal sympt/complt other

2.9

16.8

106

386

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

16.7

R03BA01

ATC

beclometasone; inhalant

2.2

16.7

190

947

R05FB02

ATC

cough suppressants and expectorants

1.7

16.6

475

3276

D07AC01

ATC

betamethasone; topical

1.7

16.6

424

2831

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

91.2

16.6

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.0

16.6

109

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

16.5

108

401

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.9

16.5

101

361

A04

ICPC

Weakness/tiredness general

2.3

16.4

166

783

R5599

NOMESCO Finland

Other rehabilitation service

5.8

16.4

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.5

16.3

234

R35

ICD-10 Finland

Polyuria

3.2

16.3

295

K07.60

ICD-10 Finland

Snapping jaw

3.4

16.3

245

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.8

16.2

108

407

R03BA08

ATC

ciclesonide; inhalant

2.6

16.2

124

506

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.6

16.0

121

492

A46

ICD-10 Finland

Erysipelas

2.2

16.0

173

844

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.1

16.0

208

1098

J01EA01

ATC

trimethoprim; systemic

1.8

15.9

324

2010

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.9

15.8

353

M01AC01

ATC

piroxicam; systemic, rectal

2.2

15.8

182

908

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.3

15.7

154

714

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.5

15.7

214

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

+∞

15.6

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

15.6

R03BA05

ATC

fluticasone; inhalant

1.9

15.6

242

1364

M48.9

ICD-10 Finland

Spondylopathy, unspecified

86.1

15.6

J31.0

ICD-10 Finland

Chronic rhinitis

2.7

15.6

110

427

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

11.9

15.6

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

22.3

15.6

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.2

15.5

271

N05CF02

ATC

zolpidem; oral

2.0

15.5

230

1275

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

15.4

106

406

N03AF01

ATC

carbamazepine; oral, rectal

3.2

15.4

261

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.1

15.4

300

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

14.9

15.4

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.5

15.4

128

547

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

15.3

330

2081

S22.3

ICD-10 Finland

Fracture of rib

3.0

15.3

324

R05

ICD-10 Finland

Cough

1.9

15.3

241

1366

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

15.3

554

4051

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

28.9

15.2

TAB00

NOMESCO Finland

Lumbar puncture

3.6

15.2

204

Z01.2

ICD-10 Finland

Dental examination

1.6

15.1

512

3676

A02BA04

ATC

nizatidine; systemic

2.7

15.1

107

417

KMAK

NOMESCO Finland

1.6

15.0

669

5146

N04BC05

ATC

pramipexole; oral

2.8

15.0

360

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.2

14.9

262

M01AB01

ATC

indometacin; systemic, rectal

2.8

14.9

372

C01DA14

ATC

isosorbide mononitrate; oral

2.2

14.9

167

825

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

14.9

144

666

N07BC02

ATC

methadone; systemic

32.1

14.8

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

14.8

353

2292

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

14.7

411

2794

RF120

NOMESCO Finland

9.8

14.7

R96

ICPC

Asthma

2.6

14.7

113

465

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

14.7

110

446

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.8

14.6

347

SPAT1240

SPAT

Therapeutic discussion

2.3

14.6

142

657

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

+∞

14.6

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

81.0

14.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

14.5

185

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

151.5

14.5

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

151.5

14.5

N06AB03

ATC

fluoxetine; oral

2.1

14.4

162

804

L15

ICPC

Knee symptom/complaint

1.9

14.3

232

1326

R4120

NOMESCO Finland

Occupational therapy

2.8

14.3

346

N06AB06

ATC

sertraline; oral

2.2

14.3

147

697

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

14.2

104

415

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

22.5

14.2

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.2

14.2

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.6

14.2

109

445

ZX120

NOMESCO Finland

Intravenous

2.3

14.2

132

598

SPAT1229

SPAT

Assessment of need for aid

2.6

14.2

103

410

N30.0

ICD-10 Finland

Acute cystitis

2.1

14.1

177

918

R1250

NOMESCO Finland

Evaluation of functional capability

5.5

14.1

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

2.1

14.1

172

880

RF210

NOMESCO Finland

4.3

14.1

125

M04AA01

ATC

allopurinol; systemic

2.2

14.1

148

711

SPAT1310

SPAT

Counselling related to known health issue

1.7

14.0

380

2557

J01FA09

ATC

clarithromycin; systemic

1.7

14.0

396

2693

R51.81

ICD-10 Finland

Facial pain NOS

5.2

14.0

J01DA08

ATC

[U] cefaclor; oral

2.2

13.9

145

693

R03AC12

ATC

salmeterol; inhalant

3.4

13.9

198

P01BA02

ATC

hydroxychloroquine; oral

2.5

13.8

111

467

D01

ICPC

Abdominal pain/cramps general

2.3

13.8

132

606

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

13.8

214

1204

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.0

13.8

142

R03AC13

ATC

formoterol; inhalant

3.3

13.8

226

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

13.8

111

468

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

13.7

264

1602

J01DA06

ATC

[U] cefuroxime; systemic

2.0

13.7

199

1094

A01AB09

ATC

miconazole; local oral

2.4

13.7

119

522

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.8

13.7

158

R03AC03

ATC

terbutaline; inhalant

2.0

13.7

183

971

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

13.7

159

799

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

13.7

488

3528

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

4.9

13.7

R50.9

ICD-10 Finland

Fever, unspecified

2.0

13.7

181

959

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

13.6

252

1508

EBA00

NOMESCO Finland

Extraction of tooth

1.6

13.6

403

2774

ZX114

NOMESCO Finland

Intramuscular

6.7

13.6

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

13.6

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

+∞

13.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

13.5

388

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

13.5

271

1664

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

141.3

13.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

13.4

364

G81.9

ICD-10 Finland

Hemiplegia, unspecified

13.0

13.4

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

13.4

387

2643

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

13.4

124

561

K10.3

ICD-10 Finland

Alveolitis of jaws

3.3

13.3

215

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.6

13.3

101

412

JAH01

NOMESCO Finland

Laparoscopy

3.1

13.3

244

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

13.3

306

1962

S80.0

ICD-10 Finland

Contusion of knee

2.7

13.2

369

P01

ICPC

Feeling anxious/nervous/tense

2.3

13.2

124

565

G57.1

ICD-10 Finland

Meralgia paraesthetica

9.2

13.2

M89.0

ICD-10 Finland

Algoneurodystrophy

9.8

13.2

RF420

NOMESCO Finland

7.6

13.2

ZXA10

NOMESCO Finland

Bilateral

1.9

13.2

226

1315

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

13.2

151

754

L84

ICPC

Back syndrome without radiat pain

3.6

13.1

169

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.5

13.1

185

M76.6

ICD-10 Finland

Achilles tendinitis

4.1

13.1

129

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.1

13.1

150

746

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

13.1

112

488

M01AX05

ATC

glucosamine; oral

1.9

13.0

222

1291

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.5

12.9

101

417

E0000UV

ATC

1.6

12.8

473

3437

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.2

12.8

128

602

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

12.8

104

441

P06

ICPC

Sleep disturbance

2.3

12.7

120

547

C07AB02

ATC

metoprolol; systemic

1.8

12.7

241

1451

G43.3

ICD-10 Finland

Complicated migraine

6.9

12.7

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

12.7

185

1016

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

12.6

318

D11

ICPC

Diarrhoea

2.1

12.6

142

701

XKD00

NOMESCO Finland

Uroflowmetry

2.0

12.5

173

931

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.5

12.5

101

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

12.5

161

842

R51

ICD-10 Finland

Headache

3.0

12.5

254

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

+∞

12.5

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

+∞

12.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.9

12.5

277

RF220

NOMESCO Finland

6.4

12.5

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

131.1

12.5

R33

ICD-10 Finland

Retention of urine

2.6

12.4

358

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.4

12.4

105

456

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

4.5

12.4

E66.00

ICD-10 Finland

Metabolic syndrome

2.9

12.4

273

XQ800

NOMESCO Finland

Prick test

2.5

12.3

101

430

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

12.3

171

924

K04.0

ICD-10 Finland

Pulpitis

2.2

12.2

131

634

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

12.1

264

1656

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

12.1

116

533

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

12.5

12.1

KH1AD

NOMESCO Finland

CT of urinary organs

3.8

12.1

134

N05AA02

ATC

levomepromazine; systemic

3.3

12.1

192

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.9

12.1

265

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

18.2

12.1

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

4.5

12.1

T78.4

ICD-10 Finland

Allergy, unspecified

3.0

12.0

237

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.2

12.0

204

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

12.0

127

610

K29.7

ICD-10 Finland

Gastritis, unspecified

3.7

12.0

145

M53.8

ICD-10 Finland

Other specified dorsopathies

21.5

12.0

J45.8

ICD-10 Finland

Mixed asthma

3.9

12.0

130

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

12.0

159

842

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

12.0

249

1542

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.6

11.9

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

11.9

226

C01CA24

ATC

epinephrine; parenteral

2.6

11.9

353

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

11.8

190

D06

ICPC

Abdominal pain localized other

2.4

11.8

101

441

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

11.7

330

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.1

11.7

136

680

SPAT1255

SPAT

Intravenous administration of medicine

2.5

11.7

377

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

5.4

11.7

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.4

11.7

SFA00

NOMESCO Finland

Small filling

2.0

11.7

160

856

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

11.6

333

N06AB05

ATC

paroxetine; oral

2.5

11.6

359

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.8

11.6

267

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.8

11.6

134

C08CA01

ATC

amlodipine; oral

1.6

11.6

384

2699

N06AA12

ATC

doxepin; systemic

2.9

11.6

261

Z00.8

ICD-10 Finland

Other general examinations

2.5

11.6

399

C10AC01

ATC

colestyramine; oral

4.2

11.6

105

L14

ICPC

Leg/thigh symptom/complaint

2.5

11.5

355

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

11.5

119

568

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

11.5

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

11.5

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

6.8

11.5

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.0

11.5

A03FA02

ATC

cisapride; oral, rectal

2.4

11.4

426

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

11.4

350

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

11.4

388

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

11.4

190

-1

NOMESCO Finland

1.6

11.4

396

2819

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

11.4

234

1444

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

11.3

142

736

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.4

11.3

P03

ICPC

Feeling depressed

2.3

11.3

110

508

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

11.3

103

463

N06AX05

ATC

trazodone; oral

4.3

11.3

A03

ICPC

Fever

1.8

11.3

197

1153

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

3.1

11.2

204

A29

ICPC

General symptom/complaint other

2.1

11.2

132

666

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

11.1

227

A11

ICPC

Chest pain NOS

2.5

11.1

360

S29

ICPC

Skin symptom/complaint other

1.8

11.1

187

1079

J01FA01

ATC

erythromycin; systemic

1.9

11.1

178

1013

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.7

11.1

254

1615

H57.1

ICD-10 Finland

Ocular pain

3.6

11.0

135

SPAT1312

SPAT

General health counselling

1.6

11.0

370

2603

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.4

11.0

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

11.0

383

R60.0

ICD-10 Finland

Localized oedema

2.1

11.0

122

598

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

11.0

394

M02AA10

ATC

ketoprofen; topical

1.8

11.0

186

1075

M01AE52

ATC

naproxen and esomeprazole; oral

3.5

11.0

146

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

11.0

108

502

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.4

11.0

157

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

10.9

108

504

RK112

NOMESCO Finland

43.7

10.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.7

10.9

271

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.6

10.9

322

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.0

10.9

143

756

P29

ICPC

Psychological sympt/compl other

2.6

10.9

304

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

10.8

305

2055

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.2

10.7

112

537

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.0

10.7

108

K59.0

ICD-10 Finland

Constipation

2.7

10.7

268

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.4

10.7

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

10.7

199

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.6

10.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

10.7

106

495

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

10.7

322

2206

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.8

10.6

119

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

10.6

649

5204

A07AA02

ATC

nystatin; oral

2.6

10.6

314

TQW30

NOMESCO Finland

Acupuncture

11.3

10.6

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.0

10.6

142

755

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

10.5

334

S06

ICPC

Rash localized

2.6

10.5

290

N03AG01

ATC

valproic acid; systemic, rectal

2.5

10.5

326

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.5

10.5

141

C05AA08

ATC

fluocortolone; rectal, topical

1.8

10.5

180

1043

M05BA04

ATC

alendronic acid; oral

2.3

10.5

427

G04CA02

ATC

tamsulosin; oral

1.7

10.5

213

1307

C08CA05

ATC

nifedipine; systemic

2.5

10.4

348

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

+∞

10.4

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

10.4

123

623

N03AX11

ATC

topiramate; oral

4.2

10.4

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

5.0

10.4

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

10.4

143

770

I20.09

ICD-10 Finland

Unstable angina

2.7

10.4

262

R32

ICD-10 Finland

Unspecified urinary incontinence

3.8

10.3

117

R01AD08

ATC

fluticasone; nasal

1.6

10.3

348

2445

ICD-10 Finland

4.3

10.3

M01AB51

ATC

indometacin, combinations; oral, rectal

4.8

10.3

G56.4

ICD-10 Finland

Causalgia

18.9

10.3

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.7

10.3

264

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.1

10.3

XF402

NOMESCO Finland

ECG with work load test

2.1

10.2

119

596

ACC51

NOMESCO Finland

Release of median nerve

2.4

10.2

385

K04.08

ICD-10 Finland

Other specified pulpit

2.4

10.2

366

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.1

10.2

114

561

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

10.1

110

537

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.0

10.1

200

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

619

3427

2.34

54.81

3.1

2.4

u/l

56.0

57.7

0.19

581

3161

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

583

3147

2.37

54.73

2.3

2.0

u/l

172.3

257.4

1.25

560

2941

(3013707) Erythrocyte sedimentation rate by Westergren method

1167

8620

2.43

49.59

5.2

3.5

mm/h

11.7

11.9

0.21

1115

7935

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

388

1837

2.48

47.87

1.3

1.2

iu/ml

27.9

33.1

0.40

105

572

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

670

4049

2.15

45.80

4.5

3.1

ng/l

28.6

69.1

1.33

447

2620

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

365

1739

2.44

44.00

1.3

1.2

u/ml

7.0

13.8

1.54

151

678

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

816

5413

2.07

42.54

8.0

6.6

mmol/l

1.2

0.13

717

4533

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1178

9002

2.29

41.97

8.8

7.1

u/l

76.5

78.0

0.62

1140

8460

(3013826) Glucose [Moles/volume] in Serum or Plasma

941

6606

2.08

41.69

6.0

4.5

mmol/l

6.7

0.04

885

6133

(3013650) Neutrophils [#/volume] in Blood by Automated count

951

6727

2.07

40.94

9.1

9.0

e9/l

4.1

0.12

855

5876

(3000850) Epithelial cells [#/volume] in Urine

422

2205

2.26

40.69

2.8

2.4

e6/l

5.4

6.7

1.37

383

1925

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

864

5932

2.03

40.05

6.3

umol/l

11.4

11.7

0.14

824

5622

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

452

2443

2.20

40.00

2.1

1.7

mg/l

1.0

1.1

0.47

356

1849

(3007853) Bacteria identified in Skin by Aerobe culture

279

1248

2.51

38.09

1.9

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1023

7544

2.05

37.84

5.9

3.8

e6/l

217.6

2044.7

1.56

118

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

622

3870

2.01

37.30

4.0

2.9

—

(3013115) Eosinophils [#/volume] in Blood

857

5961

1.98

37.20

7.3

5.8

e9/l

0.2

1.74

786

5229

(3030467) Casts [#/volume] in Urine by Automated count

505

2926

2.08

36.77

3.9

2.8

e6/l

0.3

0.5

2.11

432

2172

(3006315) Basophils [#/volume] in Blood

831

5741

1.97

36.55

6.8

5.6

e9/l

0.0

0.46

753

4971

(3019198) Lymphocytes [#/volume] in Blood

847

5901

1.96

36.22

6.8

5.6

e9/l

2.0

0.19

783

5199

(36304419) Bacteria [Presence] in Urine

495

2864

2.07

36.06

3.8

2.7

—

(3001604) Monocytes [#/volume] in Blood

827

5724

1.95

35.96

6.8

5.5

e9/l

0.6

0.11

750

4944

(3018095) Leukocytes [#/volume] in Urine

618

3875

1.99

35.91

4.4

3.3

e6/l

69.6

126.8

1.37

494

2648

(3002582) Erythrocytes [#/volume] in Urine

542

3258

2.02

35.40

3.9

2.9

e6/l

27.9

90.5

2.15

460

2469

(3037467) Urinalysis macro (dipstick) panel - Urine

1055

7972

2.01

35.05

5.4

3.8

—

(3037522) Nuclear Ab [Titer] in Serum

302

1450

2.34

35.01

1.5

1.3

titre

437.0

540.1

0.49

305

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

326

1668

2.21

32.22

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

250

1146

2.41

31.99

1.9

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

375

2039

2.11

31.66

4.1

3.2

ng/l

189.5

443.7

1.58

264

1506

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

200

830

2.62

31.60

2.6

2.2

ug/l

6.0

7.4

0.53

181

739

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

330

1715

2.17

31.28

3.3

2.5

e6/l

0.9

1.2

1.10

223

950

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

713

4870

1.86

30.57

7.4

5.9

mmol/l

1.2

0.33

659

4400

(3035350) Ketones [Presence] in Urine by Test strip

791

5588

1.85

30.36

4.7

3.1

estimate

0.0

0.00

129

1022

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

245

1139

2.37

30.27

1.8

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

797

5673

1.83

29.57

4.8

3.2

estimate

0.0

1.08

130

991

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

476

2881

1.94

29.43

3.2

2.9

ng/l

886.0

1412.6

4.03

403

2437

(3011397) Hemoglobin [Presence] in Urine by Test strip

424

2468

1.99

29.38

4.6

3.0

—

(3015736) pH of Urine

641

4286

1.85

28.98

4.5

3.0

—

5.8

—

(3026008) Bacteria identified in Urine by Culture

520

3259

1.90

28.81

4.2

2.7

—

(3032080) INR in Blood by Coagulation assay

648

4362

1.83

28.55

10.2

8.7

inr

1.2

1.3

0.97

164

1305

(3024561) Albumin [Mass/volume] in Serum or Plasma

695

4791

1.82

28.22

5.3

4.8

g/l

35.9

35.6

0.62

649

4459

(3019150) Specific gravity of Urine by Refractometry

400

2321

1.98

27.74

5.4

3.4

kg/l

1.0

2.25

345

(3021601) Nitrite [Presence] in Urine by Test strip

782

5619

1.79

27.33

6.7

4.4

estimate

0.0

0.50

133

1042

(3026782) Osmolality of Urine

371

2115

1.99

26.98

3.2

2.5

mosm/kgh2o

555.1

555.2

0.00

337

1794

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

751

5352

1.78

26.82

4.5

3.8

—

(3048689) Calprotectin [Mass/mass] in Stool

257

1282

2.20

26.65

2.4

2.3

ug/g

134.3

130.6

0.04

202

1022

(3023368) Bacteria identified in Blood by Culture

462

2857

1.88

26.23

5.3

4.1

—

(3002032) Base excess in Venous blood by calculation

202

918

2.38

26.08

4.3

3.7

mmol/l

2.2

1.9

0.48

163

733

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1402

12249

2.52

26.07

21.6

11.9

mg/l

19.9

24.0

6.02

1209

9420

(3022096) Basophils/100 leukocytes in Blood

739

5272

1.77

26.04

6.7

5.8

0.7

0.08

703

4921

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

650

4471

1.78

25.95

2.2

1.9

pmol/l

95.4

95.9

0.09

353

2338

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1146

9345

1.87

25.09

4.5

3.9

pmol/l

14.6

14.7

0.31

1074

8541

(3021447) Carbon dioxide [Partial pressure] in Venous blood

200

926

2.33

24.70

4.3

3.6

kpa

5.8

0.02

192

888

(3018010) Neutrophils/100 leukocytes in Blood

764

5560

1.74

24.62

6.8

5.6

56.6

57.2

0.66

728

5223

(3006504) Eosinophils/100 leukocytes in Blood

751

5442

1.74

24.55

6.7

5.7

2.9

2.8

0.61

716

5076

(3022217) INR in Platelet poor plasma by Coagulation assay

253

1293

2.14

24.55

18.4

24.0

inr

1.2

1.3

1.14

186

(3019069) Monocytes/100 leukocytes in Blood

754

5472

1.74

24.50

7.0

6.1

8.4

8.5

0.47

720

5127

(3026493) Urate [Moles/volume] in Serum or Plasma

465

2937

1.83

24.37

2.8

2.5

umol/l

5651.6

4639.1

0.18

418

2604

(3002030) Lymphocytes/100 leukocytes in Blood

771

5653

1.72

23.95

6.8

5.8

28.4

28.1

0.31

733

5279

(3044640) Blood type and Crossmatch panel - Blood

539

3593

1.77

23.37

2.7

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

433

2732

1.81

22.47

2.5

2.1

mg/l

3.0

2.9

0.02

383

2303

(3014576) Chloride [Moles/volume] in Serum or Plasma

245

1289

2.07

21.86

8.3

7.4

mmol/l

104.4

104.5

0.12

238

1257

(3033658) Prothrombin time (PT) actual/Normal

443

2835

1.79

21.82

5.5

3.7

92.0

91.6

0.09

431

2770

(3018418) pH of Serum or Plasma

479

3159

1.75

21.14

4.8

3.9

7.4

0.37

615

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

660

4749

1.68

21.12

2.7

2.1

nmol/l

75.6

76.6

0.42

625

4284

(42870588) Differential panel, method unspecified - Blood

553

3801

1.71

20.98

6.4

5.6

—

(3042936) Bacteria identified in Isolate by Culture

274

1523

1.97

20.91

2.7

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

304

1753

1.91

20.80

3.4

3.5

mmol/l

0.8

0.26

291

1654

(3001122) Ferritin [Mass/volume] in Serum or Plasma

696

5118

1.65

20.20

3.4

2.7

ug/l

120.9

121.5

0.02

659

4738

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

565

3955

1.67

19.73

3.9

3.1

u/l

33.8

33.5

0.04

538

3772

(3019550) Sodium [Moles/volume] in Serum or Plasma

1405

12586

2.25

19.52

22.6

13.8

mmol/l

139.6

139.7

0.86

1384

12226

(3015377) Calcium [Moles/volume] in Serum or Plasma

547

3817

1.67

19.22

2.8

3.4

mmol/l

2.3

2.4

0.26

484

3385

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1290

11229

1.89

19.20

5.4

4.5

mu/l

1.8

2.3

1.59

1217

10285

(3004119) Hemoglobin [Mass/volume] in Venous blood

137

599

2.41

19.13

4.0

2.9

g/l

128.9

128.2

0.14

132

580

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

218

1152

2.04

19.08

8.3

8.6

kpa

5.2

5.1

1.05

203

1111

(3027801) Oxygen [Partial pressure] in Arterial blood

218

1152

2.04

19.08

8.3

8.6

kpa

12.3

12.4

0.06

203

1110

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

285

1652

1.89

19.05

3.6

2.7

e6/l

4.8

2.8

1.12

181

889

(3023103) Potassium [Moles/volume] in Serum or Plasma

1407

12636

2.24

19.01

22.7

13.9

mmol/l

4.0

0.61

1383

12244

(3014111) Lactate [Moles/volume] in Serum or Plasma

177

868

2.17

18.85

7.6

8.3

mmol/l

1.3

0.04

170

840

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

386

2472

1.75

18.50

1.3

1.2

u/ml

1.2

1.5

0.41

105

654

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

193

3.47

18.48

1.4

1.3

—

(4010399)

156

735

2.25

18.32

1.6

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

189

962

2.10

18.27

2.1

nmol/l

325.3

378.7

3.34

176

882

(3021960) Folate [Moles/volume] in Serum or Plasma

381

2449

1.74

17.96

1.6

1.5

nmol/l

20.1

21.1

0.71

330

2092

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

193

3.42

17.77

1.5

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

157

752

2.21

17.70

4.3

2.8

kpa

4.6

4.7

0.28

150

719

(3003396) Base excess in Arterial blood by calculation

215

1160

1.99

17.70

8.7

8.6

mmol/l

1.2

0.07

164

930

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

230

1275

1.94

17.49

2.8

2.6

umol/l

10.4

8.5

0.49

196

1113

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

600

4366

1.61

17.41

5.3

3.3

—

(40758558) Short blood count panel - Blood

432

2897

1.68

17.33

7.2

6.5

—

(3052851) Hemolysis interference index of Serum or Plasma

311

2.83

17.02

3.4

3.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

311

1913

1.78

16.98

1.7

nmol/l

1096.3

1154.7

0.63

255

1471

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

168

845

2.11

16.72

2.6

2.8

ng/l

155.1

202.3

1.01

151

762

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

145

690

2.22

16.60

2.0

1.6

—

(3008898) HLA-B27 [Presence]

329

2.74

16.37

1.1

—

(3000330) Specific gravity of Urine by Test strip

121

543

2.33

15.91

3.4

3.2

—

(3000991) Gas panel - Venous blood

165

843

2.07

15.73

9.4

9.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

273

1661

1.78

15.34

3.0

2.1

29.4

29.6

0.18

265

1609

(3016502) Oxygen saturation in Arterial blood

191

1040

1.95

15.22

9.3

9.2

95.3

95.8

0.36

180

1008

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

402

2724

1.64

15.18

2.7

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

332

2162

1.68

14.55

1.5

1.4

g/l

2.2

2.4

0.90

203

1368

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

996

8347

1.54

14.30

3.6

2.9

u/l

54.2

46.8

1.48

948

7828

(3022948) Iron [Moles/volume] in Serum or Plasma

267

1653

1.74

14.04

2.6

2.4

umol/l

13.1

13.2

0.13

247

1529

(3005322) IgE [Units/volume] in Serum or Plasma

139

699

2.09

13.80

1.5

1.3

u/ml

164.2

175.0

0.12

131

648

(3021589) Normoblasts [#/volume] in Blood

674

5231

1.51

13.71

10.6

8.7

e9/l

0.0

0.38

574

4269

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

326

2.57

13.50

1.7

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

375

2.43

13.01

1.3

1.2

u/ml

1.7

0.9

—

(40768797) Stomach Pathology biopsy report

243

1496

1.74

12.97

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

144

752

2.01

12.89

2.4

2.3

au/ml

29.9

19.0

—

(40761535) Cells panel - Urine sediment

152

813

1.96

12.71

4.3

3.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

175

982

1.88

12.68

10.0

9.4

g/l

122.3

121.8

0.13

166

946

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

181

1033

1.85

12.43

3.3

2.2

u/l

37.1

84.5

0.53

160

908

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

109

526

2.15

12.04

9.8

11.7

mmol/l

24.6

24.3

0.41

101

502

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1251

11209

1.60

11.84

6.6

5.3

mmol/mol

40.5

39.6

2.72

1187

10377

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

949

8036

1.47

11.68

3.3

2.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

150

825

1.91

11.54

2.4

2.6

g/l

10.2

10.6

0.85

137

758

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

231

2.71

11.50

1.3

1.4

e6/l

30.2

22.0

0.14

174

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

231

2.71

11.50

1.4

1.5

e6/l

10154.4

509.9

0.49

181

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

294

1964

1.61

11.39

2.7

3.0

mmol/l

2.4

1.03

255

1736

(3004789) Transferrin [Mass/volume] in Serum or Plasma

239

1520

1.68

11.23

2.7

2.4

g/l

2.4

2.3

0.44

223

1410

(3019060) Gas panel - Arterial blood

122

640

1.98

10.78

6.2

5.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

115

591

2.02

10.77

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

207

1281

1.71

10.75

9.5

5.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

368

2624

1.53

10.65

4.8

4.1

—

(3029937) Albumin [Presence] in Urine by Test strip

402

2922

1.51

10.62

5.2

3.4

estimate

0.0

0.88

128

1007

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

222

1408

1.67

10.51

2.9

2.6

21.7

23.0

0.77

192

1212

(1761482) Bacteria [#/volume] in Urine by Culture

286

2.44

10.38

3.7

3.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1307

11955

1.60

10.01

4.8

4.2

mmol/l

6.0

5.9

2.91

1230

10915

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

139

784

1.85

9.89

4.0

4.1

ng/l

85.2

87.8

0.16

122

685

(3013512) EKG study

433

3238

1.47

9.81

4.2

3.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

216

1390

1.64

9.64

6.5

6.2

mmol/l

1.0

0.06

205

1298

(3000570) Elastase.pancreatic [Mass/mass] in Stool

284

2.38

9.60

1.5

1.4

ug/g

228.6

290.9

1.52

161

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

299

2081

1.54

9.57

1.7

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

119

649

1.90

9.40

1.8

g/l

1.4

1.6

0.20

111

599

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

473

2.05

9.34

4.6

4.1

mmol/l

24.6

24.0

1.12

439

(3025941) Bacteria identified in Stool by Culture

110

587

1.94

9.27

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

309

2.29

9.18

1.7

1.6

g/l

0.2

0.31

289

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

414

2.09

8.83

4.9

6.2

1.6

0.19

388

(3020630) Protein [Mass/volume] in Serum or Plasma

139

813

1.78

8.78

2.0

2.5

g/l

67.1

66.8

0.19

129

748

(3000475) Leukocytes [#/volume] in Synovial fluid

221

2.50

8.78

1.7

e6/l

23234.2

17826.3

0.21

162

(3017181) Myelocytes/100 leukocytes in Blood

154

928

1.73

8.77

3.4

4.1

1.6

0.9

0.96

255

(3044889) 12 lead EKG panel

965

8408

1.39

8.76

4.3

3.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1412

13262

1.73

8.63

13.2

9.3

u/l

26.4

26.2

0.30

1382

12814

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1274

11683

1.51

8.62

17.3

11.3

ml/min/173m2

83.1

82.5

0.37

1100

9562

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

405

2.08

8.58

2.5

2.1

ug/l

2.4

2.1

0.07

363

(40768804) Tissue Pathology biopsy report

599

4845

1.39

8.49

2.2

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

414

2.06

8.46

5.7

6.2

0.9

0.10

385

(3009508) Creatinine [Moles/volume] in Urine

458

3550

1.41

8.31

3.3

mmol/l

7.8

7.6

0.42

389

3022

(3026389) Candida sp identified in Specimen by Organism specific culture

128

2.94

8.31

1.7

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

109

602

1.87

8.30

1.8

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

265

2.32

8.27

1.4

1.3

mg/l

517.5

503.7

0.10

254

(3021440) Promyelocytes/100 leukocytes in Blood

146

883

1.72

8.21

3.4

4.2

0.1

0.03

237

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

247

2.36

8.21

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

475

1.97

8.19

1.6

2.0

u/l

39.7

38.2

0.37

425

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

220

1477

1.57

8.19

2.0

1.8

1.5

1.4

1.24

191

1318

(3003338) MCHC [Mass/volume]

1182

10716

1.43

8.17

26.8

15.3

g/l

332.0

332.4

0.81

1175

10627

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

327

2.16

8.04

1.7

1.6

g/l

1.2

0.05

306

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

430

2.01

8.00

1.1

—

0.8

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

3.73

7.91

3.5

3.9

nmol/l

262.9

109.4

0.41

(3022621) pH of Urine by Test strip

125

732

1.77

7.87

4.5

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

344

2.12

7.83

1.5

1.6

—

(3000494) Fungus identified in Specimen by Culture

200

1328

1.58

7.80

1.8

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

366

2.07

7.74

2.0

2.2

ug/l

258.9

1015.9

0.76

344

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

186

1218

1.60

7.69

4.2

4.5

u/l

222.1

245.9

1.96

176

1156

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

327

2.13

7.65

1.5

1.6

iu/ml

0.1

0.3

0.39

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

2.05

7.62

1.8

2.0

g/l

7.3

0.08

296

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

2.05

7.62

1.8

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

111

637

1.80

7.49

10.3

7.4

mmol/l

25.0

24.6

0.50

100

602

(3015235) Bicarbonate [Moles/volume] in Capillary blood

251

2.28

7.49

2.4

3.1

mmol/l

24.5

25.4

0.82

212

(3025159) Blasts/100 leukocytes in Blood

136

829

1.70

7.44

3.5

4.2

0.0

0.9

0.91

197

(40761511) CBC panel - Blood by Automated count

1382

12992

1.59

7.38

18.2

11.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

374

2.03

7.32

1.8

2.0

g/l

4.1

3.9

0.19

280

(3024891) Influenza virus A+B Ag [Presence] in Specimen

300

2.15

7.28

1.3

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

151

952

1.65

7.27

7.1

8.2

mmol/l

8.6

9.6

1.14

140

903

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

328

2.09

7.22

3.7

2.9

u/ml

0.3

0.4

0.31

189

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

325

2423

1.43

7.20

1.7

1.6

pmol/l

95588650.8

33746707.1

0.79

272

2018

(44816559) Phosphatidylethanol [Mass/volume] in Blood

212

2.35

7.12

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

182

2.46

7.05

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

109

634

1.77

7.04

3.3

3.5

kpa

5.2

0.13

103

589

(3036603) Volume of Urine

3.42

6.98

1.6

1.7

1865.0

2217.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

208

2.35

6.95

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

348

2.03

6.88

1.8

2.0

g/l

9.8

10.7

1.17

299

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

210

2.33

6.81

1.7

1.2

u/ml

3.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

138

865

1.65

6.80

2.5

2.3

ml/min/173m2

70.7

67.3

0.50

332

(3009343) pH of Capillary blood

107

626

1.76

6.78

3.4

7.4

0.16

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

360

1.99

6.62

1.8

2.0

g/l

3.0

3.1

0.54

287

(3012516) Albumin [Mass/volume] in Urine

419

3307

1.37

6.57

3.4

3.3

mg/l

492.5

344.3

0.23

293

2116

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

306

2.07

6.56

1.9

g/l

39.3

37.7

1.44

264

(3044941) Cell count panel - Synovial fluid

141

2.59

6.47

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

336

2.01

6.43

1.8

2.2

g/l

0.6

1.3

1.35

294

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

102

598

1.76

6.43

3.2

3.5

mmol/l

2.2

1.8

0.53

444

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

570

1.77

6.35

11.4

12.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

171

1148

1.55

6.34

2.3

2.8

1.9

1.8

0.43

157

1023

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

3.27

6.29

1.7

2.3

e9/l

0.2

0.26

(3002179) Metamyelocytes/100 leukocytes in Blood

133

843

1.63

6.29

3.3

3.9

0.8

0.5

0.29

186

(36660697) Celiac disease serology panel - Serum

137

875

1.62

6.28

1.2

—

(3011288) Drugs identified in Urine by Screen method

258

2.13

6.23

3.5

3.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

265

2.12

6.21

1.2

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

117

721

1.67

6.17

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

220

2.22

6.14

1.5

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

301

2.03

6.10

1.8

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

152

2.47

6.05

3.1

3.0

—

(3045414) Leukocytes [Presence] in Urine

459

1.83

6.04

1.6

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

289

2.05

6.01

1.6

1.2

u/ml

40.6

28.4

—

(3022145) Colonoscopy Study observation

180

1238

1.51

5.98

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

224

2.18

5.89

1.3

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

160

1078

1.54

5.84

2.2

g/l

0.2

0.30

145

1008

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

3.10

5.78

1.7

2.2

e6/l

480.2

473.3

0.03

(3033705) Calcium.ionized [Moles/volume] in Venous blood

126

2.57

5.72

3.4

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

109

674

1.66

5.69

2.1

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

109

2.69

5.68

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1332

12558

1.43

5.63

5.2

4.5

mmol/l

2.8

1.31

1246

11602

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1314

12360

1.42

5.61

4.7

4.1

mmol/l

4.7

4.8

1.42

1239

11512

(3014765) Yersinia sp identified in Stool by Organism specific culture

304

1.98

5.60

1.3

1.1

—

(44806118)

134

2.49

5.55

1.2

1.5

—

(44790049)

134

2.49

5.55

1.2

1.5

—

(44790047)

134

2.49

5.55

1.2

1.5

—

(44790048)

134

2.49

5.55

1.2

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

192

1359

1.47

5.54

1.5

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

110

689

1.64

5.47

2.2

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

432

3509

1.32

5.43

4.1

mg/mmol

10.6

8.2

0.46

293

2251

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

469

1.77

5.37

2.3

2.0

g/l

1.5

0.07

405

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

302

1.96

5.35

1.3

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

569

1.69

5.33

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

310

1.94

5.31

1.3

1.1

—

(3020891) Body temperature

369

1.85

5.24

7.5

4.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

163

2.30

5.23

1.3

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1265

11859

1.36

5.22

4.2

3.7

mmol/l

1.5

1.3

6.64

1181

10912

(3041096) Erythrocytes [Presence] in Urine by Automated

395

3189

1.32

5.15

4.2

3.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.87

5.09

1.6

1.5

31.0

27.0

0.16

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

2.18

5.00

1.2

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

310

1.90

4.98

1.5

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

268

1.97

4.96

1.7

1.2

u/ml

3.6

3.0

0.19

(3006184) Hemoglobin [Mass/volume] in Capillary blood

220

2.08

4.96

1.8

2.2

g/l

131.4

132.5

0.10

171

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

270

1.96

4.87

1.7

1.2

u/ml

2.8

12.3

1.03

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1301

12283

1.37

4.86

4.6

4.1

mmol/l

1.4

1.5

6.30

1219

11363

(3047181) Lactate [Moles/volume] in Blood

335

1.85

4.83

6.3

7.3

mmol/l

1.3

0.14

288

(3023183) Ammonium ion [Moles/volume] in Plasma

236

2.02

4.83

2.4

3.2

umol/l

43.0

36.9

0.38

213

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

2.24

4.80

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

274

2117

1.36

4.78

1.9

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

157

1100

1.48

4.78

2.0

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

2.69

4.76

1.4

e6/l

19181.5

148407.0

0.87

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

525

1.68

4.75

2.1

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

287

1.91

4.73

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.71

4.65

2.1

2.8

—

(3019225) pH of Specimen

156

1098

1.47

4.64

3.9

4.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.16

4.63

1.2

1.7

umol/l

60.6

99.6

—

(3023520) Reticulocytes [#/volume] in Blood

124

834

1.53

4.60

2.2

3.0

e9/l

70.9

0.01

626

(3002385) Erythrocyte distribution width [Ratio]

1122

10404

1.28

4.57

24.4

14.9

13.8

13.6

1.83

1112

10151

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

320

1.84

4.55

1.8

3.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

131

894

1.51

4.54

3.6

3.2

mmol/l

1.2

0.05

122

759

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.67

4.50

1.6

1.4

g/l

6.3

7.3

0.67

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.67

4.50

1.6

1.4

g/l

3.0

2.9

0.11

(4062490)

2.67

4.50

1.6

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.67

4.50

1.6

1.4

g/l

0.4

0.53

(3023323) Follitropin [Units/volume] in Serum or Plasma

605

1.61

4.47

1.5

1.4

iu/l

26.5

30.0

0.49

519

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

536

1.64

4.41

2.6

2.4

—

(3021901) Oxygen saturation in Capillary blood

176

2.13

4.40

2.2

2.8

—

(1761868) Lipid panel - Serum or Plasma

406

4849

0.78

4.40

2.8

2.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

268

1.89

4.30

2.2

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

283

1.87

4.27

1.2

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.58

4.22

1.5

1.2

—

73.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

214

1.99

4.19

2.5

1.6

pmol/l

191.2

214.1

0.64

204

(3017143) Hepatitis C virus Ab [Presence] in Serum

180

1328

1.40

4.16

1.8

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

3.00

4.13

1.9

1.7

ug/l

7.0

8.7

0.25

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1288

0.63

4.09

1.6

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

216

1.97

4.09

1.2

1.1

u/ml

5.9

1.6

0.36

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

129

2.27

4.07

1.1

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.35

4.04

1.6

1.3

1.2

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

1447

13998

1.51

3.98

30.0

17.8

g/l

134.8

135.7

1.54

1433

13771

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.55

3.97

2.1

2.2

e6/l

719.3

678.7

0.11

(40768443) Skin Pathology biopsy report

473

1.64

3.95

1.3

1.2

—

(3024731) MCV [Entitic volume]

1446

13989

1.51

3.95

29.8

17.7

91.1

90.8

1.26

1430

13763

(3026361) Erythrocytes [#/volume] in Blood

1446

13992

1.50

3.91

29.9

17.7

e12/l

4.5

1.25

1419

13558

(3035941) MCH [Entitic mass]

1446

13992

1.50

3.91

29.7

17.7

30.3

0.44

1430

13764

(4198724)

3.28

3.91

4.9

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

374

1.71

3.91

1.8

1.9

u/l

4021.8

5516.0

0.21

160

(3007461) Platelets [#/volume] in Blood

1445

13982

1.50

3.89

29.9

17.7

e9/l

255.5

253.4

0.62

1422

13590

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.19

3.89

1.2

—

(3010813) Leukocytes [#/volume] in Blood

1446

13995

1.50

3.87

29.9

17.8

e9/l

6.9

6.7

2.98

1420

13558

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

120

2.27

3.81

1.3

1.4

nmol/l

—

(3024263) Appearance of Synovial fluid

3.08

3.81

1.5

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.35

3.76

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

134

2.19

3.74

1.9

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

297

1.78

3.70

3.0

2.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

275

1.81

3.69

1.2

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

167

1243

1.39

3.68

2.1

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

103

2.35

3.67

1.5

1.2

nmol/l

1.7

1.3

0.91

(3021788) Differential panel - Synovial fluid

162

2.06

3.67

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.49

3.64

1.7

1.1

u/ml

48.8

43.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

2.55

3.63

1.3

1.2

promille

1.2

0.07

(3011412) CD3 cells [#/volume] in Blood

104

2.33

3.60

1.8

2.3

e9/l

1.1

0.02

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.76

3.59

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

440

1.62

3.53

2.4

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

389

3273

1.25

3.51

4.9

4.5

ug/l

5.1

2.5

0.38

346

2923

(3023410) Appearance of Cerebral spinal fluid

112

2.25

3.49

1.8

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

859

0.59

3.48

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

3.35

3.48

1.9

4.8

14.7

2.01

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

2.19

3.39

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

101

2.30

3.36

1.4

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

578

1.52

3.27

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

309

1.71

3.26

1.5

2.1

mg/l

11.3

12.5

0.42

283

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

394

1.62

3.26

2.3

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

257

1.77

3.24

1.5

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

280

1.74

3.22

2.2

2.4

ug/min

120.4

87.4

0.27

172

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.59

3.20

1.1

1.3

—

21.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.87

3.19

1.0

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

207

1.86

3.19

1.4

1.2

u/ml

26.2

30.6

—

(3024928) Oxygen saturation in Venous blood

222

1.82

3.17

4.2

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

314

2607

1.26

3.16

4.6

3.9

21.3

21.6

0.12

142

1221

(3016879) Cocaine [Presence] in Urine

369

1.62

3.07

2.6

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

153

1162

1.35

3.00

2.8

4.5

ug/l

3.1

22.2

1.75

118

939

(3009214) Lutropin [Units/volume] in Serum or Plasma

294

1.69

2.99

1.4

1.3

u/l

10.7

10.4

0.05

237

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

120

2.10

2.99

1.2

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.02

2.97

1.6

1.2

—

(4027681)

2.48

2.96

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.29

2.94

3.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

343

1.63

2.91

1.3

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.69

2.87

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

393

1.57

2.83

2.7

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.07

2.81

1.9

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

8.35

2.75

1.6

1.5

umol/l

53.2

38.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.32

2.75

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.44

2.71

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.44

2.71

3.3

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

197

1.79

2.69

2.5

—

(3028300) Cannabinoids [Presence] in Urine

399

1.55

2.67

2.4

2.2

—

(3027944) Amphetamines [Presence] in Urine

392

1.55

2.64

2.7

2.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.20

2.57

5.0

2.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

178

1.81

2.56

1.0

u/ml

1.1

2.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

436

1.51

2.55

1.5

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

103

755

1.39

2.55

3.4

pmol/l

4.2

4.5

3.70

664

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

5.47

2.54

1.0

1.2

—

75.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

157

1.86

2.53

2.1

1.8

g/l

0.7

0.9

0.51

114

(3051611) Lipemic interference index of Serum or Plasma

115

2.02

2.51

3.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

232

1.70

2.50

3.6

5.7

iu/ml

306.4

410.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

102

751

1.38

2.47

2.3

2.0

nmol/l

12.8

0.00

683

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

103

2.05

2.42

3.9

2.1

u/field

3.4

2.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

197

1.74

2.40

1.1

u/ml

2.2

5.4

1.42

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.01

2.40

1.2

1.1

85.8

96.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.01

2.40

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

298

1.60

2.38

2.2

1.7

nmol/l

38.4

39.2

0.10

288

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.76

2.37

1.5

2.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

168

1.80

2.37

1.3

1.5

—

(3017732) Neutrophils [#/volume] in Blood

106

791

1.37

2.37

3.1

3.3

e9/l

4.6

4.0

1.19

648

(3027008) Opiates [Presence] in Urine

396

1.51

2.34

2.5

2.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.32

2.31

4.9

3.2

mu/l

25.8

31.8

0.29

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

329

0.48

2.31

1.4

1.5

—

(3036489) Thrombin time

430

1.48

2.31

2.8

1.9

19.9

21.0

1.57

379

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

155

1.82

2.30

1.1

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

301

1.58

2.29

2.6

3.1

mg/l

33.0

61.5

0.68

245

(3034860) Kappa light chains.free [Mass/volume] in Serum

301

1.58

2.29

2.7

3.1

mg/l

42.3

73.9

0.81

242

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

178

1.76

2.27

1.2

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.57

2.27

1.3

3.0

u/ml

1225.5

1785.8

0.34

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

113

1.96

2.26

3.5

2.0

mg/l

24.1

23.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.90

2.25

2.0

2.1

mmol/l

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

113

860

1.34

2.24

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.35

2.22

1.1

—

(3039000) Anion gap in Blood

233

1.65

2.21

8.0

8.9

mmol/l

11.8

11.3

0.35

210

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

1.94

2.21

1.2

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

114

1.94

2.21

1.0

1.1

—

(3018572) Chloride [Moles/volume] in Blood

234

1.64

2.18

8.0

8.8

mmol/l

104.9

105.1

0.08

211

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

196

1.70

2.16

1.6

1.3

—

72.5

—

(3052592) Norovirus Ag [Presence] in Stool

3.70

2.15

1.1

1.5

—

(3022313) Gas panel - Capillary blood

462

1.45

2.15

3.9

3.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.31

2.15

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.31

2.15

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.01

2.15

1.3

1.6

ug/l

10.4

9.3

—

(3000492) Spirometry study

145

1151

1.29

2.14

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.22

2.11

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

213

1.66

2.11

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

1.94

2.11

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

1.94

2.11

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

1.94

2.11

1.3

1.6

—

(3028433) Virus identified in Specimen by Culture

2.71

2.10

1.0

1.3

—

(21494755) Public health laboratory ask at order entry panel

107

1383

0.76

2.08

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.09

2.07

1.9

1.8

nmol/l

19.2

18.8

0.07

(1616796) Gas panel - Central venous blood

216

1.63

2.01

2.3

3.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

170

1.72

2.01

1.7

1.4

u/l

26.8

30.3

0.19

140

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.97

1.93

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.97

1.93

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.97

1.93

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.97

1.93

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

1.77

1.93

1.2

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

544

0.64

1.93

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

180

1.68

1.92

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

106

1.90

1.91

2.6

—

(3003181) Sodium [Moles/volume] in Urine

158

1.72

1.89

1.4

1.3

mmol/l

69.4

59.1

0.41

126

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

212

1785

1.22

1.88

1.7

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.19

1.88

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.19

1.88

1.4

2.5

umol/l

9.8

19.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

375

1.46

1.86

1.5

1.3

miu/ml

118.1

237.3

1.90

173

(3023419) Bacteria identified in Sputum by Culture

129

1.79

1.86

1.7

2.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

107

833

1.31

1.85

1.2

iu/ml

130.9

158.5

0.29

319

(4211845)

2.40

1.85

4.2

2.4

—

(3034770) Mitochondria Ab [Titer] in Serum

311

1.49

1.82

1.4

1.2

—

910.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.07

1.80

3.7

2.6

42.0

42.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

1.79

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

360

3193

1.17

1.78

1.8

1.6

mmol/l

1.6

1.4

2.09

321

2682

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.91

1.75

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.94

1.75

1.5

umol/l

14.4

12.0

0.48

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

201

1.60

1.75

1.2

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

308

0.55

1.72

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.85

1.71

1.0

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

307

0.55

1.71

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

306

0.55

1.69

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

306

0.55

1.69

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.19

1.67

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

149

1.69

1.67

1.2

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.98

1.64

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.98

1.64

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.98

1.64

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

411

1.40

1.64

1.4

1.6

mu/l

224.3

312.5

3.16

375

(3023430) Cat dander IgE Ab [Units/volume] in Serum

150

1.68

1.64

1.1

u/ml

2.1

2.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

189

1.60

1.63

1.2

1.1

u/ml

0.7

1.8

0.77

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

221

1.55

1.63

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

263

0.53

1.61

1.4

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

246

1.52

1.61

1.1

1.2

—

(4034850)

362

1.42

1.61

12.3

7.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

363

1.42

1.59

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.01

1.58

7.5

13.0

mmol/l

4.6

5.1

—

(3002619) Bacteria identified in Specimen by Culture

3.01

1.58

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.01

1.58

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

129

1.72

1.57

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.93

1.54

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.93

1.54

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.93

1.54

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

130

1.70

1.53

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

115

1.75

1.53

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.34

1.52

2.2

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

185

1.58

1.52

1.2

1.1

u/ml

2.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.60

1.51

7.1

5.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

226

1.52

1.49

2.7

3.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

256

0.54

1.49

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

101

1.79

1.49

1.1

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

1.50

1.47

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.23

1.46

1.1

—

(3005033) Fetal Nuchal fold Thickness US

254

0.55

1.46

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.85

1.46

4.1

2.1

—

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

294

1.44

1.45

3.7

3.3

mg/l

16.9

25.5

1.77

193

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.13

1.44

1.0

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.13

1.44

2.2

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.13

1.44

1.0

1.3

ng/l

96.0

93.9

—

(4015189)

2.73

1.43

1.8

2.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

229

1.50

1.42

1.1

1.2

u/ml

308.0

260.9

0.32

138

(3005570) Glucose [Moles/volume] in Urine

126

1.68

1.40

1.7

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.78

1.39

1.9

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

2.01

1.38

1.2

1.3

nmol/l

136.2

133.3

0.08

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.81

1.37

1.3

u/ml

0.0

0.8

0.88

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.61

1.37

1.0

mg/g

7.1

6.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.95

1.36

1.0

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.95

1.36

1.0

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.95

1.36

1.0

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

167

1.57

1.35

1.1

1.0

u/ml

10.6

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.97

1.33

1.3

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.97

1.33

1.3

2.1

—

(40768441) Liver Pathology biopsy report

1.82

1.31

1.3

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.51

1.30

3.2

2.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.51

1.30

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.89

1.28

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.78

1.28

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

122

1.65

1.27

1.4

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

186

1.51

1.27

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

2.05

1.27

4.8

2.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.41

1.24

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

123

1.63

1.24

1.6

2.1

umol/l

3.2

6.6

1.68

(4306422)

179

1.52

1.24

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

460

1.32

1.24

1.8

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.77

1.23

1.1

—

(3049717) Cytology report of Urine Cyto stain

374

1.35

1.22

2.2

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.75

1.19

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

109

1.66

1.19

6.4

5.3

u/ml

18.5

42.0

—

(3009871) Measles virus Ab [Titer] in Serum

2.11

1.18

1.6

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.94

1.17

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1194

11609

1.12

1.17

22.5

13.2

38.8

39.9

2.77

855

8657

(3001019) Free T4 and TSH panel - Serum or Plasma

789

0.78

1.16

1.8

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.50

1.15

1.0

3.2

—

(3020650) Glucose [Presence] in Urine

0.00

1.15

0.0

1.4

—

(3010503) CD19 cells [#/volume] in Blood

1.81

1.15

1.5

2.4

e9/l

0.2

0.24

(3044242) Glucose [Moles/volume] in Arterial blood

1.85

1.13

1.3

2.8

—

(3051651) Icteric interference index of Serum or Plasma

1.76

1.13

4.5

4.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

225

1.43

1.12

1.2

1.4

u/ml

110.4

129.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.01

1.12

10.1

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.01

1.12

10.1

2.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

408

1.31

1.09

2.8

3.9

u/ml

79.8

902.5

1.22

355

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

244

1.40

1.08

1.2

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

202

1.44

1.08

2.3

2.4

17.1

16.9

0.09

100

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

253

1.39

1.07

1.2

1.4

—

22.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

203

1.44

1.05

2.1

1.7

—

(40768800) Prostate Pathology biopsy report

191

0.57

1.04

1.1

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

136

1171

1.18

1.02

3.7

3.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.77

1.00

1.0

—

(4094501)

317

1.33

1.00

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

135

0.52

0.98

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.18

0.98

1.2

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.95

0.97

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.95

0.97

1.1

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.74

0.96

1.1

1.0

ng/l

951.3

610.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.74

0.96

8.8

7.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.77

0.94

1.0

1.1

iu/ml

105.2

259.9

—

(4281824)

144

0.55

0.93

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.72

0.92

1.1

1.0

ng/l

202.8

320.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.72

0.92

1.1

1.0

ng/l

32.7

49.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.82

0.92

1.1

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

358

0.72

0.88

1.5

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.00

0.87

1.2

1.0

—

(3014271) Vancomycin [Susceptibility]

1.78

0.84

3.8

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

214

1937

1.12

0.82

2.8

ug/l

0.6

0.7

2.99

131

1229

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.70

0.82

1.6

—

(44813793)

1.70

0.82

1.2

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.70

0.82

2.9

1.8

u/field

1.0

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.88

0.82

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.82

0.79

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.67

0.78

1.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.67

0.78

1.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.67

0.78

1.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.67

0.78

1.2

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

199

1.36

0.78

1.2

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.50

0.77

10.0

11.7

nmol/l

803.0

827.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

256

0.70

0.76

1.4

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.09

0.74

7.8

5.8

—

(3051593) INR in Capillary blood by Coagulation assay

1.80

0.72

1.1

14.1

—

(3017569) Oxygen content in Arterial blood

1.61

0.72

1.3

3.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.61

0.72

2.8

3.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.93

0.70

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.93

0.70

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.71

0.70

1.9

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

169

1.37

0.69

1.2

1.4

mmol/l

7.8

7.2

0.47

117

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.79

0.66

1.0

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

403

1.22

0.66

1.6

1.4

—

(40761536) Microorganisms panel - Urine sediment

997

0.87

0.64

3.9

3.4

—

(4146454)

112

1.43

0.63

2.4

2.8

—

(3037121) Protein [Mass/volume] in Urine

397

1.22

0.62

2.5

3.4

g/l

0.4

0.3

0.46

170

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

121

1.41

0.62

1.2

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.55

0.62

1.2

1.5

—

(3047189) Immunofixation for 24 hour Urine

1.64

0.62

1.6

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

131

1176

1.12

0.62

1.5

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

183

1.32

0.59

2.5

5.7

umol/l

364.3

378.3

0.32

161

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

192

1.31

0.59

1.6

nmol/l

0.4

0.3

0.04

149

(40757373) Influenza virus identified in Isolate

0.00

0.58

0.0

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

225

2087

1.09

0.58

1.6

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.48

0.57

1.3

1.4

—

(3044007) Cell count panel - Peritoneal fluid

1.67

0.56

2.7

2.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

195

0.72

0.56

1.3

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.46

0.56

1.3

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

311

1.23

0.56

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

228

0.74

0.54

1.3

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.47

0.54

2.0

1.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.50

0.54

2.1

2.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.54

0.53

1.2

1.6

pmol/l

13.2

13.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

197

1.27

0.51

1.4

1.2

u/ml

4.0

3.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.47

0.50

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

1.43

0.49

1.8

1.7

mmol/l

8.1

7.1

—

(4268621)

136

1.33

0.49

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

154

1.30

0.48

1.2

1.1

—

(3012501) Base excess in Blood by calculation

235

1.24

0.48

1.9

3.8

mmol/l

2.8

2.7

0.04

162

(3025130) Human papilloma virus identified in Specimen

173

1.28

0.46

1.5

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.43

0.45

1.1

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.43

0.45

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

118

1077

1.10

0.45

1.5

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

147

1.30

0.45

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.40

0.45

2.7

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

183

1.26

0.45

1.3

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

202

1.24

0.43

2.9

3.0

nmol/l

0.8

0.10

156

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

193

1.25

0.43

1.3

1.2

u/ml

1.9

3.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.41

0.43

1.1

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.61

0.43

2.4

2.5

ug/l

14.5

19.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.3

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.43

0.42

1.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.3

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

140

1.29

0.42

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.41

0.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

213

1.22

0.41

2.2

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.40

1.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

223

1.21

0.39

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

223

1.21

0.39

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

223

1.21

0.39

1.8

3.9

u/ml

822.9

1727.7

0.29

213

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.34

0.39

1.0

1.1

—

(44806420)

1.43

0.39

1.8

2.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.43

0.39

1.2

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.43

0.39

1.0

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

226

0.79

0.39

1.9

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.35

0.38

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

197

1.22

0.37

1.4

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

112

0.71

0.37

2.1

1.5

g/l

0.9

1.0

—

112

(3014148) Varicella zoster virus Ab [Titer] in Serum

143

1.26

0.37

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

126

1.27

0.35

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

126

1.27

0.35

1.3

1.5

—

(3034426) Prothrombin time (PT)

1.40

0.35

1.5

1.2

—

(40768795) Lymph node Pathology biopsy report

145

0.76

0.34

1.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.32

0.33

1.9

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.33

0.33

2.0

2.4

—

(4024509)

100

1.30

0.33

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

1.26

0.33

1.3

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

127

1.26

0.33

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.28

0.32

1.2

1.0

miu/ml

1470.5

1629.6

—

(3035880) pH of Pleural fluid

1.28

0.32

1.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

146

1.24

0.32

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

128

1.25

0.32

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

128

1.25

0.32

1.3

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.32

0.31

1.1

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.29

0.30

1.4

3.2

63.0

55.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.23

0.29

1.1

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.23

0.29

2.7

2.4

nmol/l

207.4

145.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

158

1.21

0.28

2.1

1.7

mmol/l

1.8

1.6

0.34

153

(40768793) Breast Pathology biopsy report

332

0.87

0.27

1.1

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

320

0.87

0.26

1.5

2.1

iu/l

2.1

5.4

—

117

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

149

0.80

0.25

2.2

2.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

170

1.18

0.24

1.5

3.1

0.7

1.4

—

134

(21494434) Karyotype in Bone marrow

1.25

0.24

1.3

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.24

0.23

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.75

0.22

1.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.22

0.22

4.2

3.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.22

0.22

1.2

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.21

0.0

2.8

—

283.2

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.16

0.21

3.2

2.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

183

1.15

0.20

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

114

0.79

0.20

2.1

3.7

—

(3045424) Erythrocytes [Presence] in Urine

194

1.14

0.18

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.21

0.18

1.1

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

528

0.93

0.18

1.6

mg/l

4.7

4.0

0.14

374

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

142

0.84

0.17

1.1

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

474

0.93

0.16

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.16

0.16

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.14

0.16

1.3

1.4

—

(3042631) Mycobacterium sp identified in Specimen

140

1.14

0.15

1.4

2.4

—

(3045788) Cell count panel - Pleural fluid

0.79

0.14

1.6

1.5

—

(3012441) Differential panel - Pleural fluid

0.82

0.13

1.5

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

104

1.16

0.12

1.2

1.4

mmol/l

13.1

12.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

149

1450

1.03

0.11

4.4

4.2

31.6

32.2

0.22

991

(3003694) ABO and Rh group [Type] in Blood

340

3452

0.98

0.10

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

222

1.08

0.10

3.0

59.1

57.6

0.26

222

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.11

0.09

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.11

0.09

1.4

1.5

—

(3012565) Volume of 24 hour Urine

1.09

0.09

1.7

2.9

3690.0

1964.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

204

1.08

0.08

1.0

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.14

0.08

1.3

1.4

mmol/l

6.0

6.6

—

(3015183) Erythrocyte sedimentation rate

1.08

0.07

1.4

1.1

—

(3045142) Bone marrow Pathology biopsy report

137

1.10

0.07

1.3

—

(4035726)

113

1107

1.02

0.06

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.11

0.05

1.5

1.8

—

(40768806) Pleura Pathology biopsy report

109

0.92

0.04

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

119

0.92

0.04

1.0

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

210

1.05

0.03

3.1

2.8

e9/l

4.3

4.2

0.06

210

(1002224) Polysomnography panel

561

1.02

0.02

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

104

1.06

0.01

1.1

1.0

—

(3002256) Pathology report gross observation

157

1566

1.00

0.00

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

105

0.95

0.00

2.0

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3011648) Oxygen content in Venous blood

0.99

0.00

1.1

2.1

10.8

11.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.4

—

0.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

2.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

2.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.9

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.94

0.00

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.95

0.00

1.1

1.6

—

(3004451) EKG impression Narrative

0.96

0.00

1.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.2

—

393.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

14.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.94

0.00

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.02

0.00

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_PANNICULITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_PANNICULITIS	1.578 [1.42, 1.75]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.048

During the follow-up period (1.1.1998 — 31.12.2019), 1665 out of 6737 females with M13_PANNICULITIS died.

Males

Parameter	HR [95% CI]	p-value
M13_PANNICULITIS	1.505 [1.33, 1.71]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 1019 out of 4499 males with M13_PANNICULITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_PANNICULITIS.

N-year risk	Females	Males
1	0.143%	0.272%
5	0.799%	1.826%
10	1.882%	4.562%
15	3.762%	8.391%
20	6.781%	14.191%

Relationships between endpoints

↥

Index endpoint: M13_PANNICULITIS – Panniculitis affecting regions of neck and back

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Panniculitis affecting regions of neck and back

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints